(MENAFN- GlobeNewsWire - Nasdaq) Clinical Microbiology Market Growth Fueled by Reagent Innovation, Advanced Instrumentation, and Increasing Prevalence of Respiratory and Bloodstream Infections Worldwide.

Austin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Clinical Microbiology Market Size & Growth Analysis

According to SNS Insider, the global Clinical Microbiology Market was valued at USD 4.3 billion in 2023 and is projected to reach USD 7.4 billion by 2032, expanding at a compound annual growth rate (CAGR) of 5.9% over the forecast period 2024–2032. The market's steady growth is driven by the continuous development of diagnostic reagents, the increasing global burden of infectious diseases, and technological innovations in laboratory instruments. The market's upward momentum reflects the growing critical need for rapid and precise microbial identification to improve patient outcomes and manage global health challenges.

Get free Sample Report of Clinical Microbiology Market:

Major Players in the Clinical Microbiology Market Include:

• Hardy Diagnostics
• Bruker
• Danaher
• bioMerieux SA
• Abbott
• F. Hoffmann-La Roche Ltd.
• BD
• Bio-Rad Laboratories, Inc.
• Hologic, Inc.
• Arrow Diagnostics Srl
• Shimadzu Corporation
• Cole-Parmer Instrument Company, LLC
• Thermo Fisher Scientific Inc.
• Memmert GmbH + Co
• Agilent Technologies, Inc.
• Neogen Corporation and Other Key Market Participants

Clinical Microbiology Market Report Scope

Report Attributes	Details
Market Size in 2023	US$ 4.3 Billion
Market Size by 2032	US$ 7.4 billion
CAGR	CAGR of 5.9% From 2024 to 2032
Base Year	2023
Forecast Period	2024-2032
Historical Data	2020-2022
Key Segments	By Product (Laboratory Instruments, Automated Culture System, Reagents) By Disease (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, Other Diseases)
Regional Analysis/Coverage	North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America).

Clinical Microbiology Market Segment Insights

By Product

In 2023, the reagents segment led the clinical microbiology market, holding a dominant share of 72.2%. This prominence is primarily due to the ongoing development and commercialization of advanced reagents tailored for clinical microbiology. The laboratory instruments segment is projected to exhibit the fastest growth rate from 2024 to 2032. The surge in demand for laboratory equipment, which includes essential tools, such as incubators, gram stainers, bacterial colony counters, autoclave sterilizers, and petri dish fillers, is fueling this rapid expansion

By Disease

In 2023, the respiratory diseases segment led the market with a 28.7% share, driven by the increasing incidence of infectious diseases, such as tuberculosis. From 2024 to 2032, the bloodstream infection (BSI) category is projected to increase at the fastest rate. Growing rates of chronic diseases, more invasive medical procedures, an aging population, and the presence of antibiotic-resistant bacteria are some of the causes contributing to the global increase in BSI cases, which is a serious public health concern.

By Region

In 2023, North America led the clinical microbiology market, commanding a revenue share of 39.2%. The U.S. market is experiencing strong growth due to the high prevalence of infectious diseases and the challenges posed by emerging pathogens.

In the Asia Pacific region, the clinical microbiology market is projected to have the highest CAGR, fueled by advancements in healthcare and innovative medical technologies. China's market growth is driven by increased awareness of infectious diseases, higher healthcare spending, and advancements in diagnostic technologies.

Buy the Clinical Microbiology Market Report Now:

Recent News:

• January 2024: BioMérieux acquired LUMED, a software company, to enhance antimicrobial stewardship and improve infection control programs. This strategic acquisition aims to bolster BioMérieux's capabilities in managing and controlling infections through advanced software solutions.
• February 2024: Becton, Dickinson, and Company (US) partnered with Camtech Health (Singapore) to improve cervical cancer screening. The collaboration introduces an innovative solution allowing women in Singapore to collect samples privately at home, enhancing accessibility and convenience for cervical cancer diagnostics.

Exclusive Sections of the Report (The USPs):

• DISEASE INCIDENCE & PREVALENCE BENCHMARKS – helps you understand the global and regional burden of infectious diseases, guiding demand projections for diagnostic and microbiology testing solutions.
• PRESCRIPTION & DIAGNOSTIC UTILIZATION TRENDS – helps you analyze prescribing patterns and diagnostic testing frequency across regions, identifying markets with high testing volumes and clinical adoption.
• DEVICE VOLUME & INSTALLATION INDEX – helps you track the deployment and usage rate of microbiology instruments and consumables from 2020–2032, revealing capacity expansion and technology penetration.
• HEALTHCARE SPENDING DISTRIBUTION MATRIX – helps you evaluate funding sources across government, private, and commercial sectors to understand regional affordability and infrastructure investment levels.
• REGIONAL MARKET PERFORMANCE INDICATORS – helps you compare clinical demand drivers, prescription rates, and spending efficiency across key geographies to pinpoint high-growth opportunities.

Access Complete Report Details of Clinical Microbiology Market Analysis & Outlook:

[For more information or need any customization research mail us at...]

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email:...

MENAFN28102025004107003653ID1110259275